Literature DB >> 8473130

Prevalence of metronidazole-resistant Helicobacter pylori in dyspeptic patients.

H X Xia1, M A Daw, S Beattie, C T Keane, C A O'Morain.   

Abstract

Susceptibility to metronidazole of 213 clinical strains of H. pylori from dyspeptic patients was determined by a plate dilution method. Seventy two (33.8%) of the strains were resistant to metronidazole (MIC > 8 mg/L), 20 of these were from 24 patients who had received previously metronidazole (83.3%), giving a primary (pretreatment) resistance rate of 27.5% (52/189). The resistance rate was higher in women than in men, especially aged 50 to 59 years old (43.6% vs 23.3%, p < 0.001). The resistance rate was lower in patients at 60 or over (9.8%), but similar between the younger patients groups (38.8% - 49.0%). There was no difference in the resistance rate between peptic ulcer disease (32.6%) and nonulcer dyspepsia (34.7%). These data indicated that metronidazole resistance in H. pylori is absolutely associated with previous use of the drug, and the higher resistance rate in women may be due to the more frequent prescription of the drug for their gynaecological infection or operation. Therefore, testing of susceptibility of H. pylori to metronidazole is important. A new susceptibility testing technique, the E-test was evaluated in this study and found to give comparable results to the plate dilution method and also had the advantage of being simple to perform.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8473130     DOI: 10.1007/bf02942098

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  12 in total

1.  Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria.

Authors:  C N Baker; S A Stocker; D H Culver; C Thornsberry
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

2.  Metronidazole resistance in Helicobacter pylori.

Authors:  Y Glupczynski; A Burette; E De Koster; J F Nyst; M Deltenre; S Cadranel; L Bourdeaux; D De Vos
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

3.  Metronidazole-resistant Helicobacter pylori.

Authors:  M C Becx; A J Janssen; H A Clasener; R W de Koning
Journal:  Lancet       Date:  1990-03-03       Impact factor: 79.321

4.  Role of metronidazole resistance in therapy of Helicobacter pylori infections.

Authors:  H Rautelin; K Seppälä; O V Renkonen; U Vainio; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

5.  Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori.

Authors:  B J Marshall; C S Goodwin; J R Warren; R Murray; E D Blincow; S J Blackbourn; M Phillips; T E Waters; C R Sanderson
Journal:  Lancet       Date:  1988 Dec 24-31       Impact factor: 79.321

6.  Helicobacter pylori and duodenal ulcer recurrence.

Authors:  S Patchett; S Beattie; E Leen; C Keane; C O'Morain
Journal:  Am J Gastroenterol       Date:  1992-01       Impact factor: 10.864

7.  Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination.

Authors:  J Weil; G D Bell; K Powell; A Morden; G Harrison; P W Gant; P H Jones; J E Trowell
Journal:  Aliment Pharmacol Ther       Date:  1990-12       Impact factor: 8.171

8.  Prevention of nitroimidazole resistance in Campylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies.

Authors:  C S Goodwin; B J Marshall; E D Blincow; D H Wilson; S Blackbourn; M Phillips
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

9.  Experience with 'triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance.

Authors:  G D Bell; K Powell; S M Burridge; A Pallecaros; P H Jones; P W Gant; G Harrison; J E Trowell
Journal:  Aliment Pharmacol Ther       Date:  1992-08       Impact factor: 8.171

10.  The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis.

Authors:  C S Goodwin; P Blake; E Blincow
Journal:  J Antimicrob Chemother       Date:  1986-03       Impact factor: 5.790

View more
  9 in total

1.  Clarithromycin resistance in Helicobacter pylori and its clinical relevance.

Authors:  Hua-Xiang Xia; Xue-Gong Fan; Nicholas J Talley
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

2.  Management of dyspepsia in primary care. GPs are already choosing eradication therapy over endoscopy.

Authors:  R Boutet
Journal:  BMJ       Date:  1998-05-02

3.  Culture of Helicobacter pylori under aerobic conditions on solid media.

Authors:  H X Xia; C T Keane; C A O'Morain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-05       Impact factor: 3.267

4.  Eradication of Helicobacter pylori: the results of a pilot study of 3, 5 & 7 day triple antibiotic regime with bismuth for one month.

Authors:  H J O'Connor; K Cunnane; J S Collins; J M Sloan; B T Johnston; K C Bamford; J Gilvarry; C A O'Morain
Journal:  Ir J Med Sci       Date:  1997 Jan-Mar       Impact factor: 1.568

5.  Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation.

Authors:  R J Cahill; H Xia; C Kilgallen; S Beattie; H Hamilton; C O'Morain
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

6.  Metronidazole resistance reduces efficacy of triple therapy and leads to secondary clarithromycin resistance.

Authors:  M J Buckley; H X Xia; D M Hyde; C T Keane; C A O'Morain
Journal:  Dig Dis Sci       Date:  1997-10       Impact factor: 3.199

7.  Effect of Helicobacter pylori eradication on peptic ulcer healing.

Authors:  H J O'Connor; C Kanduru; A S Bhutta; J M Meehan; K M Feeley; K Cunnane
Journal:  Postgrad Med J       Date:  1995-02       Impact factor: 2.401

8.  Metronidazole-resistant Helicobacter pylori is more prevalent in patients with nonulcer dyspepsia than in peptic ulcer patients in a multiethnic Asian population.

Authors:  Sook-Yin Lui; Khay-Guan Yeoh; Bow Ho
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

9.  Standardization of disk diffusion test and its clinical significance for susceptibility testing of metronidazole against Helicobacter pylori.

Authors:  H Xia; C T Keane; S Beattie; C A O'Morain
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.